{
  "id": "05dfd3f91a866b50",
  "title": "Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine Potential to Slow the Progression of Dementia with Lewy Bodies",
  "description": "20260106T130000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/01/06/tmt-newswire/globenewswire/cognition-therapeutics-publishes-phase-2-clinical-results-showing-zervimesines-potential-to-slow-the-progression-of-dementia-with-lewy-bodies/2253590",
  "published_at": "20260106T130000Z",
  "fetched_at": "2026-01-07T00:22:40.638561+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/01/06/tmt-newswire/globenewswire/cognition-therapeutics-publishes-phase-2-clinical-results-showing-zervimesines-potential-to-slow-the-progression-of-dementia-with-lewy-bodies/2253590",
    "url_mobile": "https://www.manilatimes.net/2026/01/06/tmt-newswire/globenewswire/cognition-therapeutics-publishes-phase-2-clinical-results-showing-zervimesines-potential-to-slow-the-progression-of-dementia-with-lewy-bodies/2253590/amp",
    "title": "Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine Potential to Slow the Progression of Dementia with Lewy Bodies",
    "seendate": "20260106T130000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/01/06/889368.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}